ArticleCell death & disease2021
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib.
Jianyong Zhuo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it